Innovative, high-quality medical education for clinicians in cardiology and other specialties.
Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
Richard Lafayette, MD, FACP
Ankana Daga, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Ahmad Masri, MD, MS
Michael Nassif, MD, MSc
Anjali Owens, MD
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
Molecular Precision: How Myosin Inhibitors Redefine Control
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
Cracking the Code of Obstruction: Unmet Needs in oHCM
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD